TY - JOUR
T1 - Guidelines for the treatment of empyema (The Japanese Association for Chest Surgery)
AU - Shiraishi, Yuji
AU - Omasa, Mitsugu
AU - Yamashita, Shinichi
AU - Hyung-eun, Yoon
AU - Tanahashi, Masayuki
AU - Fukami, Takeshi
AU - Tokyooka, Shinichi
AU - Ode, Yasuhisa
AU - Okamoto, Tatsuro
AU - Shiraishi, Takashi
AU - Shintani, Yasushi
AU - Hida, Yasuhiro
AU - Maeda, Sumiko
AU - Matsumoto, Isao
AU - Sakairi, Yuichi
AU - Fukui, Mariko
AU - Okuda, Katsuhiro
AU - Tsuchida, Masanori
AU - Iyoda, Akira
AU - Saji, Hisashi
AU - Yoshino, Ichiro
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to The Japanese Association for Thoracic Surgery 2025.
PY - 2025/5
Y1 - 2025/5
N2 - This article translates the guidelines for the treatment of empyema established by the Japanese Association of Chest Surgery in 2023 from Japanese to English. These guidelines were developed by the Working Group on Guidelines for the Treatment of Empyema of our society, involving the establishment of clinical questions, conducting systematic reviews in accordance with the MINDS (Medical Information Distribution Service) Manual for Guideline Development 2020 version 3.0 and the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) system, and determining the levels of recommendations. Furthermore, external evaluators provided assessments. Subsequently, the guidelines were finalized after receiving public comments from the members of the society. Even in the current era of advanced antibiotic therapy, empyema remains difficult to treat. However, the specific guideline for the treatment of empyema lacks in our country. Each institution is conducting clinical practices in its own way. Therefore, aiming to standardize the treatment of empyema, we have developed a practice guideline of empyema treatment. The pathophysiology of empyema is diverse, so empyema is classified into acute, chronic, and postoperative empyema. The recommended surgical treatment for each type of empyema is described, being categorized by the strength of recommendation, strength of evidence, and consensus rate.
AB - This article translates the guidelines for the treatment of empyema established by the Japanese Association of Chest Surgery in 2023 from Japanese to English. These guidelines were developed by the Working Group on Guidelines for the Treatment of Empyema of our society, involving the establishment of clinical questions, conducting systematic reviews in accordance with the MINDS (Medical Information Distribution Service) Manual for Guideline Development 2020 version 3.0 and the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) system, and determining the levels of recommendations. Furthermore, external evaluators provided assessments. Subsequently, the guidelines were finalized after receiving public comments from the members of the society. Even in the current era of advanced antibiotic therapy, empyema remains difficult to treat. However, the specific guideline for the treatment of empyema lacks in our country. Each institution is conducting clinical practices in its own way. Therefore, aiming to standardize the treatment of empyema, we have developed a practice guideline of empyema treatment. The pathophysiology of empyema is diverse, so empyema is classified into acute, chronic, and postoperative empyema. The recommended surgical treatment for each type of empyema is described, being categorized by the strength of recommendation, strength of evidence, and consensus rate.
KW - Decortication
KW - Empyema
KW - Open window thoracostomy
KW - Surgery
UR - https://www.scopus.com/pages/publications/85219736851
UR - https://www.scopus.com/inward/citedby.url?scp=85219736851&partnerID=8YFLogxK
U2 - 10.1007/s11748-025-02119-0
DO - 10.1007/s11748-025-02119-0
M3 - Article
C2 - 39969668
AN - SCOPUS:85219736851
SN - 1863-6705
VL - 73
SP - 312
EP - 327
JO - General Thoracic and Cardiovascular Surgery
JF - General Thoracic and Cardiovascular Surgery
IS - 5
M1 - e4
ER -